This snapshot, taken on 04/01/2012, shows web content selected for preservation by The National Archives. External links, forms and search boxes may not work in archived websites.
The National Health Service (NHS) spends about £9 billion a year on branded prescription medicines in the UK. The Pharmaceutical Price Regulation Scheme (PPRS) is the mechanism which the Department of Health (on behalf of the UK health departments) uses to ensure that the NHS has access to good quality branded medicines at reasonable prices. The scheme seeks to achieve a balance between reasonable prices for the NHS and a fair return for the industry to enable it to research, develop and market new and improved medicines.
Updated list of Category C products (updated January 2011) referred to at paragraph 7.44.1 of the 2009 PPRS
